Que Pharma is primarily engaged in products that based on oral drug delivery since its inception in 1981. Through the experience of 3 decades we have been able to develop various formulations that caters the critical need of that therapeutic class.
It is our constant endeavor to study the existing drug delivery system and identify the shortfalls that occurs using them. Through specialist material science skills, processes and proprietary technologies, we develop and provide products that have which cater to these specific needs.
At Que Pharma, we expertise in development of oral dose forms including:
- Customized controlled-release drug delivery
- Bioavailability enhancement
- Taste masking (liquid and solid dosage forms)
- Fast release tablets
- Melt-in-mouth tablets
- Smaller sized Solid orals (for Better Geriatric and Paediatric Patient Compliance)
When applied appropriately, these technologies can potentially deliver the following therapeutic and convenience benefits to patients:
- Better patient compliance
- Improved efficacy and therapeutic effect
- Lower adverse effects
- Revitalizing old products
Some of the innovative products are as below
1. RACIMOL TABLETS
(FAST RELEASE PARACETAMOL 500 MG AND 650 MG)
Paracetamol is one of the oldest NSAID used in the treatment of Pyrexia, different types of mild to moderate pain and inflammation. Due its versatile action and low adverse reactions, it is still the first choice of drug in pyrexia and pain management.
Our fast release Paracetamol, Racimol, shows a dissolution rate of >75% within first 5 mins at all pH range. Paracetamol is quickly absorbed from the stomach (empty as well as fed) giving effect very early as compared that in conventional tablets.
2. ONDA-Q MD
(ONDANSETRON MOUTH DISSOLVING TABLETS)
Ondansetron is a very bitter tasting drug used as antiemetic. We have developed a completely taste-masked formulation for better patient compliance. The disintegration time for the tablets is 5-6 seconds in mouth as well as in-vitro.